Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000509

Drug Information
NameDyclonine
SynonymsDyclocainum; Dyclonin; Dyclonine [INN:BAN]; 1-(4-Butoxy-phenyl)-3-piperidin-1-yl-propan-1-one; 4-n-butoxy-beta-(1-piperidyl)propiophenone; NINDS_000632; DB00645; STK524544; Dycloninum [INN-Latin]; AC-12286; UNII-078A24Q30O; BRD-K72259270-003-05-8; Spectrum5_000951; dyclonine; BAS 00363810; Spectrum2_001013; 1-Propanone, 1-(4-butoxyphenyl)-3-(1-piperidinyl)- (9CI); CAS-536-43-6; NCGC00016498-02; CID3180; AKOS000505031; CHEBI:4724; AC1L1FCQ; Tanaclone; KBio2_001496; Diclonina [INN-Spanish]; Prestwick3_000264; NCGC00016498-01; 586-60-7; KBio1_000632; Dyclocaine; Spectrum_001016; 4'-Butoxy-3-piperidinopropiophenone; 1-(4-butoxyphenyl)-3-(piperidin-1-yl)propan-1-one; Spectrum3_000410; BSPBio_000108; PROPIOPHENONE, 4'-BUTOXY-3-PIPERIDINO-; Prestwick2_000264; Dyclothane; IDI1_000632; Spectrum4_000529; BRN 0224037; C07881; MolPort-001-926-955; Diclonina; SPBio_002327; 4-butoxy-beta-piperidinopropiophenone; KBio2_006632; KBio3_001160; KBioGR_001137; Diclonia; DivK1c_000632; SPBio_001165; AB00053467; KBioSS_001496; Prestwick1_000264; Dycloninum; STOCK1S-04530; 1-(4-Butoxyphenyl)-3-(1-piperidinyl)-1-propanone; LS-125084; KBio2_004064; Prestwick0_000264; D07881; 3-Piperidino-4'-butoxypropiophenone; BPBio1_000120; 1-(4-butoxyphenyl)-3-piperidin-1-ylpropan-1-one; 1-Propanone, 1-(4-butoxyphenyl)-3-(1-piperidinyl)-; BSPBio_001940; 2-(1-piperidyl)ethyl p-butoxyphenyl ketone; 536-43-6 (hydrochloride); Dyclonine (INN)
IndicationAnesthetic
[ICD9: 338   ICD10: R52]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C18H27NO2/c1-2-3-15-21-17-9-7-16(8-10-17)18(20)11-14-19-12-5-4
-6-13-19/h7-10H,2-6,11-15H2,1H3
InChIKeyBZEWSEKUUPWQDQ-UHFFFAOYSA-N
Canonical SMILESCCCCOC1=CC=C(C=C1)C(=O)CCN2CCCCC2    
Therapeutic ClassAnesthetics
CAS NumberCAS 586-60-7
FormulaC18H27NO2
PubChem Compound IDCID 3180.
PubChem Substance IDSID 10083.
SuperDrug ATC IDN01BX02; R02AD04
SuperDrug CAS ID000586607;
TargetSodium channel protein type 5 subunit alphaBlocker[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 009925 To Reference
Ref 2Monoamine transporter and sodium channel mechanisms in the rapid pressor response to cocaine. Pharmacol Biochem Behav. 1998 Feb;59(2):305-12. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543